Evaluation of the Efficacy and Safety of Gelsectan in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome

Clinical trial NCT07000383 · RECRUITING

Trial details

NCT number: NCT07000383
Sponsor: University Medical Center Ho Chi Minh City (UMC)
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Diarrhea-predominant Irritable Bowel Syndrome Irritable Bowel Syndrome of Diarrhea Type (IBS-D)

Start date: 2025-06-15
Primary completion: 2026-07-30
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.